Follow-up | Criterion | CCM | EAPM | P valuea |
---|---|---|---|---|
2nd year | BRA | 80.5% (99/123) | 76.5% (101/132) | 0.441 |
ND | 52.0% (64/123) | 58.3% (77/132) | 0.312 | |
Atrophy | 34.2% (42/123) | 54.5% (72/132) | 0.001 | |
Skin change* | 37.4% (46/123) | 46.2% (61/132) | 0.154 | |
Scar | 33.3% (41/123) | 56.1% (74/132) | < 0.001 | |
5th year | BRA | 81.2% (95/117) | 75.0% (93/124) | 0.246 |
ND | 50.4% (59/117) | 54.0% (67/124) | 0.575 | |
Atrophy | 32.5% (38/117) | 44.4% (55/124) | 0.058 | |
Skin change* | 38.5% (45/117) | 47.6% (59/124) | 0.153 | |
Scar | 34.2% (40/117) | 55.7% (69/124) | 0.001 | |
10th year | BRA | 80.6% (87/108) | 74.8% (86/115) | 0.302 |
ND | 50.0% (54/108) | 52.2% (60/115) | 0.746 | |
Atrophy | 30.6% (33/108) | 44.4% (51/115) | 0.034 | |
Skin change* | 40.7% (44/108) | 47.0% (54/115) | 0.350 | |
Scar | 30.6% (33/108) | 55.7% (64/115) | < 0.001 |